EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians
Panelists discuss Melinda's experience with her lung cancer diagnosis, including her symptoms, diagnostic tests (such as imaging and blood work), and the progression of her condition, as well as the concerns and questions she had when referred to Dr. Spira for treatment options, while also exploring the steps Dr. Spira took to confirm the diagnosis of EGFR-mutant NSCLC and evaluate the appropriate treatment approach.
Video content above is prompted by the following:
Can you walk us through your experience surrounding your lung cancer diagnosis?
What symptoms did you experience at your time of diagnosis and how did they progress?
What tests did you undergo to confirm your diagnosis (e.g., imaging, blood work) and what was the outcome?
Upon referral, what were your thoughts when considering your treatment options?
What questions or concerns did you have for him and his care team?
What specific worries or anxieties were at the forefront of your mind?
Once Melinda was referred to your office, what steps did you take to evaluate and confirm diagnosis of EGFR-mutant NSCLC?
